Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
2017
827 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
26.61
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours | Researchclopedia
AbbVie (United States)
Roberto M. Risi
·
AbbVie (United States)
Robin R. Frey
·
AbbVie (United States)
Vlasios Manaves
·
AbbVie (United States)
Bailin Shaw
·
AbbVie (United States)
Mikkel A. Algire
·
AbbVie (United States)
Paul Hessler
·
AbbVie (United States)
Lloyd T. Lam
·
AbbVie (United States)
Tamar Uziel
·
AbbVie (United States)
Emily J. Faivre
·
AbbVie (United States)
Debra C. Ferguson
·
AbbVie (United States)
Fritz G. Buchanan
·
AbbVie (United States)
Ruth L. Martin
·
AbbVie (United States)
Maricel Torrent
·
AbbVie (United States)
Gary G. Chiang
·
Fate Therapeutics (United States)
Kannan R. Karukurichi
J. William Langston
·
Faraday Technology (United States)
Brian T. Weinert
·
University of Copenhagen
Chunaram Choudhary
·
Novo Nordisk Foundation
Peter de Vries
Arthur F. Kluge
Michael A. Patane
·
IIT@MIT
John H. Van Drie
Ce Wang
·
Novartis (China)
David McElligott
Ed Kesicki
Ronen Marmorstein
·
University of Pennsylvania
Chaohong Sun
·
AbbVie (United States)
Philip A. Cole
·
Johns Hopkins University
Saul H. Rosenberg
·
AbbVie (United States)
Michael R. Michaelides
·
AbbVie (United States)
Albert Lai
·
AbbVie (United States)
Kenneth D. Bromberg
·
AbbVie (United States)